Skip to main content Start main content

PolyU discovers a newly emerged superbug -- hyper-resistant and hypervirulent Klebsiella pneumoniae

29 Aug 2017


The Partner State Key Laboratory of Chirosciences at the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) discovered a newly emerged superbug, hyper-resistant and hypervirulent Klebsiella pneumoniae, which may cause untreatable and fatal infections in relatively healthy individuals and will pose enormous threat to human health.

Prof. Chen Sheng, Professor of ABCT, collaborating with Prof. Rong Zhang from the Second Affiliated Hospital of Zhejiang University, conducted an investigation into a fatal outbreak of pneumonia in the Second Affiliated Hospital of Zhejiang University in China in February 2016. The study involved five patients who underwent surgical operation for multiple-trauma. All of them were later infected in the intensive care unit (ICU) and developed severe pneumonia, and eventually died of septicaemia and multiple organ failure. The causative agent of these five patients was found to be a carbapenem-resistant K. pneumoniae (CRKP) strain, a type of previously-defined superbug. Furthermore, these CRKP strains are also hypervirulent and belong to ST11 type of CRKP, the most prevalent and transmissible CRKP strains in Asia. As these strains simultaneously exhibit the features of hyper-resistance, hypervirulence and high transmissibility, they can be considered a real superbug known asST11 CR-HvKP (ST11 carbapenem-resistant hypervirulentK. pneumoniae).

ST11 K. pneumoniae strains proliferate in the gastrointestinal tract (GI tract) of human and animals and may cause opportunistic infections such as pneumonia in clinical settings. These strains, after acquiring plasmid encoding a carbapenemase gene, become resistant to the carbapenem antibiotics and caused untreatable or hard-to-be treated infections, therefore defined as superbug. These superbug strains could further evolve to become ST11 CR-HvKP through acquisition of the hypervirulence plasmids. The ST11 CR-HvKP strains do not only infect lungs and cause pneumonia, but also invade the bloodstream and other internal organs. Due to its hypervirulence and phenotypic resistance to commonly used antibiotics, ST11 CR-HvKP strains may cause untreatable and fatal infections in relatively healthy individuals with normal immunity.

ST11 CR-HvKP strains possess a mucoid outer layer, which enables them to stick to various materials, such as the surface of medical devices and tubing as well as other surfaces in the ICU. The transmission route is not clear yet, but our data suggest that medical equipment such as ventilator and different catheters might be transmitting these new superbug strains. Human-to-human transmission may also be possible, mainly in hospital settings. Improved infection prevention and control policy in hospital seems to be effective to control further transmission of this superbug in the ICU. Novel strategies must be devised to prevent ST11 CR-HvKP from proliferating extensively in the human intestinal tract where they were detected. ST11 CR-HvKP can easily be detectable by the Polymerase chain reaction (PCR) method, targeting specific resistance and virulence genes. The study showed that the use of colistin (the last resort drug for carbapenem-resistant enterobacteriaceae infections) alone or in combination with other drugs were not very effective in treating infections caused by ST11 CR-HvKP. Ceftazidime/avibactam may be the effective antibiotic, but ST11 CR-HvKP may develop resistance to this antibiotic very quickly based on the clinical data from the USA.

Prevalence of ST11 CR-HvKP strains in Hong Kong is currently unknown. Two studies conducted in Hong Kong have shown that mortality rate due to K. pneumoniae-mediated bloodstream infections was high, reaching 20% and 32% respectively. We plan to collaborate with clinicians in local hospitals to investigate the proportion of clinical K. pneumoniae isolates that belong to HvKP or CR-HvKP, and characterize their genetic features.

理大發現新發性超級細菌 ─ 高抗藥性和高毒力肺炎克雷伯菌 (Chinese)

Media Headline Date
晴報 P18 理大發現新超級肺炎惡菌 一旦感染 無藥可治 1 Sep 2017
信報財經新聞 A16 理大發現超級抗藥新惡菌 1 Sep 2017
香港商報 A15 理大發現新型高抗藥性超級細菌 1 Sep 2017
明報 A11 揭內地現抗藥毒菌 理大擬港醫院調查 1 Sep 2017
文匯報 A11 理大揭新抗藥惡菌 依附醫療儀傳肺炎 1 Sep 2017
成報 A07 理大發現新超級惡菌 暫5人染病亡 1 Sep 2017
大公報 A02 高傳播高毒力 浙江五病人感染亡 進化超級肺炎菌 無藥可救 1 Sep 2017
東方日報 A10 內地爆新超級肺炎惡菌 1 Sep 2017
香港特別行政區政府 - 新聞公報 食物及衞生局局長在北京與新聞界談話內容 1 Sep 2017
蘋果日報 A07 內地現新型抗藥惡菌 死亡率極高 1 Sep 2017
The Standard P08 New superbug warning after deadly outbreak 1 Sep 2017
頭條日報 P08 理大發現新超級惡菌 高抗藥性內地奪五命 1 Sep 2017
都市日報 P10 5人感染全死亡 新惡菌高毒抗藥 1 Sep 2017
AM730 A02 暫時無藥醫 港嚴陣以待 內地現新型 超級惡菌 1 Sep 2017
經濟日報 A22 港人染抗藥惡菌趨增 險無藥可用 1 Sep 2017
TVB 普通話新聞報道 00:12:39-00:13:50 31 Aug 2017
Now TV 午間新聞 02:26 – 03:34 31 Aug 2017
Cable TV 理大發現內地肺炎與新超級細菌有關 31 Aug 2017
RTHK 午間新聞天地 00:07:56-00:10:06 31 Aug 2017
RTHK Hong Kong Today 1:13:35 - 1:19:04 31 Aug 2017
RTHK 本港內地團隊發現超級細菌 暫無有效療法 31 Aug 2017
CRHK 881903 理大發現新型高毒性及高抗藥性肺炎菌 31 Aug 2017
Metro Broadcast 理大發現一種新型高毒力和高傳播性的超級細菌 31 Aug 2017
Bastille Post 理大發現高抗藥性超級細菌 致命感染無法治癒 31 Aug 2017
蘋果日報 A10 理大發現內地超級惡菌 10日奪命 31 Aug 2017
The Lancet A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study 29 Aug 2017


Research Units Department of Applied Biology and Chemical Technology

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here